HK inno.N's anti-cancer drug targeting non-small cell lung cancer (NSCLC) has been selected by the Korea Drug Development Foundation (KDDF) as part of the "New Drug R&D Ecosystem Building Research" project.The project is a cross-sectoral R&D program where the KDDF supports the entire life cycle of n
Genome&Company, a prominent name in the microbiome domain, has underscored its robust progress in the realm of cancer research. Genome&Company co-CEO Pae Ji-soo said the company would seek a technology transfer for two of its anticancer candidates by the year's end. This decision is attributed to du
JW Shinyak said it will resume sales of SK bioscience's influenza vaccine, SKY Cellflu Quardrivalent Prefilled Syringe.SKY Cellflu Quardrivalent is a cell-culture influenza vaccine developed by SK bioscience that protects against four types of influenza viruses -- including two types of influenza A
Hanmi Pharm has taken the first step toward clinical trials of BH3120, a double-antibody anticancer drug candidate it is developing as its next-generation pipeline.According to the Ministry of Food and Drug Safety (MFDS), Hanmi received approval for a phase 1 clinical trial of BH3120 on Friday. Hanm
JW Pharmaceutical said on Friday that it received approval to conduct phase 3 clinical trials in Taiwan for its gout drug, epaminurad (URC102).This marks the first time epaminurad has received approval for a phase 3 IND in a foreign country. The company has already submitted an IND to regulatory age
Researchers at Yonsei University College of Medicine (YUCM) have found that SGLT-2 inhibitors, commonly prescribed to diabetes patients, are effective in reducing the symptoms of non-alcoholic steatohepatitis (NASH).Non-alcoholic fatty liver disease (NAFLD) occurs due to the accumulation of fat in t
Lundbeck is drawing the industry’s attention by saying it would begin a phase 2 clinical trial of an autoimmune disease candidate it licensed in (L/I) from Korean biotech Aprilbio.Through a conference call for the first half-year on Wednesday (local time), Lundbeck announced it plans to start the ph
MSD Korea has joined hands with Seventeen, a Korean idol group, to raise awareness of the importance of HPV (human papillomavirus) prevention.The company said Thursday that it has selected global influencer Seventeen as the ambassador for its HPV prevention campaign.The company produced a TV campaig
HK inno.N said that it has entered into an exclusive distribution and co-commercialization agreement with Roche Korea for the latter's Xofluza, a once-daily antiviral treatment for influenza.Under the agreement, HK inno.N will be responsible for the distribution of Xofluza for two years, and Roche K
Lotte Healthcare said on Wednesday that it signed a memorandum of understanding (MOU) with iMediSync, a digital mental health management platform company, to jointly develop healthcare models based on artificial intelligence (AI).Founded in 2012, iMediSync specializes in the measurement of brainwave
Celltrion said on Monday that its consolidated revenue for the second quarter of this year was 524 billion won ($393 million won) and operating income was 183 billion won, down 12.1 percent and 10.1 percent year-on-year, respectively. Net profit was down 18 percent to post 151 billion won. Celltrion
CG Bio, a Korean developer of spinal disorder and wound management solutions, said on Monday its Advanced LumFix Spinal Fixation System (Advanced LumFix), an implant and surgical device for spinal correction, has received 510(k) clearance from the U.S. FDA.With the approval, Advanced LumFix is expec
Handok has voluntarily withdrawn its IND (Investigational New Drug) application for a domestic phase 2/3 clinical trial of its biliary tract cancer treatment after failing to meet the Ministry of Food and Drug Safety (MFDS) requirements.The industry’s attention is now on its impact on the global cli
JW Pharmaceutical, which has been hitting new highs in share prices for 52 consecutive weeks, met the market’s expectations by posting a record performance in the second quarter.On Wednesday, JW Pharm released preliminary operating results for the second quarter in a public filing.On a standalone ba
Prestige Biopharma said on Friday that it signed a memorandum of understanding (MOU) with Imagion Biosystems, a U.S. imaging diagnostics company, to develop an early diagnosis platform for pancreatic cancer. Under the partnership, Prestige Biopharma will provide pancreatic adenocarcinoma up-regulate
MSD Korea has recently applied for expanding reimbursement for Keytruda (pembrolizumab) to cover all its 13 cancer indications with high unmet needs.Among indications newly requested for coverage are triple-negative breast, head and neck, and esophageal cancers, which are aggressive enough to threat
Just a few weeks after the official launch of Samsung Bioepis and Organon’s Humira (ingredient: adilumab) biosimilar, Hadlima, in the U.S. market, it is quickly gaining traction, after being added to two large U.S. insurers.This marks the fourth U.S. insurer to register the drug. Previously, Prime T
Children's cold medicines suspended due to quality control issues are back on the market after improvements.The Ministry of Food and Drug Safety said Thursday that it had lifted the suspension of manufacturing and sales of Dong-A Pharmaceutical's Champ Syrup and Daewon Pharmaceutical's Coldaewon Kid
Hugel said it recorded the largest second quarterly earnings in its history, thanks to strong sales from its botulinum toxin, fillers, and cosmetic lineup.The company's sales and operating profit for the second quarter was 81.6 billion won ($61.9 million) and 21.4 billion won, both up 28 percent com
BL Science, a subsidiary of BL Pharmtech, said on Thursday that it signed an agreement with Kumoh National Institute of Technology, a local university, to jointly develop a cancer diagnosis solution utilizing artificial intelligence (AI) in tissue and cellular pathology diagnosis.BL Science is a dia